Medical Devices China

China Bariatric Surgery Devices Market Analysis, 2024–2034

Updated Reviewed by Chandani Patel

China Bariatric Surgery Devices Market Industry Trends and Forecast to 2034: Segmented by (Device, Procedure, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034

Overview

Market Dashboard

China · 2024–2034 · placeholder estimates

Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.

Estimate 2024 $206.2 Mn Placeholder estimate
Estimate 2025 $221.6 Mn 8.6% of the global market
Projected 2034 $425.0 Mn 91.7% Adds $203.3 Mn over 9 forecast years
CAGR 2025–2034 7.5% Faster than 17% of 173 Medical Devices markets here
Key players 6 +1
  • China is 8.58% of the global market.
  • In APAC, the largest is China (this report) at $221.6 Mn.
  • Fastest growing: India at 9.1% a year.
  • China ranks 1st of 10 by size in APAC.

Market size projection

China

Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.

Value added each year

$203.3 Mn total, 2026–2034

Year-by-year market size, 2024–2034
Bariatric Surgery Devices Market market size by year, China
YearMarket sizeChange that yearSince 2025
2024 (estimate) $206.2 Mn — —
2025 (base) $221.6 Mn +$15.5 Mn —
2026 (forecast) $238.3 Mn +$16.6 Mn +7.5%
2027 (forecast) $256.1 Mn +$17.9 Mn +15.6%
2028 (forecast) $275.4 Mn +$19.2 Mn +24.2%
2029 (forecast) $296.0 Mn +$20.7 Mn +33.5%
2030 (forecast) $318.2 Mn +$22.2 Mn +43.6%
2031 (forecast) $342.1 Mn +$23.9 Mn +54.3%
2032 (forecast) $367.7 Mn +$25.7 Mn +65.9%
2033 (forecast) $395.3 Mn +$27.6 Mn +78.3%
2034 (forecast) $425.0 Mn +$29.6 Mn +91.7%

Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.

Report snapshot

China Bariatric Surgery Devices Market Analysis at a glance
Market size, 2025$221.6 Mn placeholder estimate
Forecast, 2034$425.0 Mn placeholder estimate
Growth (CAGR), 2025–20347.5% placeholder estimate
Years2024 historical · 2025 base year · 2026–2034 forecast
SegmentsDevice, procedure and end user (see all)
Key playersJohnson & Johnson, Medtronic, Apollo Endosurgery, Olympus Corporation, Intuitive Surgical and 1 more (see all)
Regulator in ChinaNMPASource: National Medical Products Administration. Checked 14 Nov 2026.
Active clinical trials20 in ChinaSource: ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in China. Retrieved 12 Nov 2026.
FormatsPDF, PPTX, XLSX

Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.

The China Bariatric Surgery Devices Market Analysis Executive Summary

Bariatric surgery devices are the staplers, bands, balloons and endoscopic tools used in weight-loss surgery and procedures.

Key segments of the bariatric Surgery Devices market include device (Stapling Devices, Gastric Bands and Intragastric Balloons) and procedure (Sleeve Gastrectomy, Gastric Bypass and Endoscopic Sleeve Gastroplasty).

Bar chart: China Bariatric Surgery Devices market size, 2024–2034, placeholder estimates. $206.2 Mn in 2024, $221.6 Mn in 2025 and $425.0 Mn in 2034, 7.5% CAGR.
China Bariatric Surgery Devices market size, 2024–2034. Placeholder estimates; researched figures come with the full report. Source: Acuitas Health Analytics.

China Bariatric Surgery Devices Market Dynamics

Market Growth Drivers

Rising rates of obesity and type 2 diabetes, strong clinical results for new weight-loss medicines and growing acceptance of obesity as a chronic disease are driving the bariatric Surgery Devices market. Wider insurance coverage and more doctors trained in obesity care are adding to demand.

Opportunity

Oral formulations, combination therapies and use in heart, kidney and liver disease open new growth paths for the bariatric Surgery Devices market, especially in fast-growing emerging economies.

Market Restraints

High treatment prices, limited reimbursement, supply shortages and side effects that lead some patients to stop treatment hold back the bariatric Surgery Devices market. Long-term safety data and lifestyle support are still needed for many patients.

Competitive Landscape for Bariatric Surgery Devices Market in China

The bariatric Surgery Devices market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.

Key Players

Healthcare Policies and Regulatory Landscape for Bariatric Surgery Devices Market in China

Bariatric Surgery Devices in China: rules, payment and research

Medical devices are regulated by the National Medical Products Administration (NMPA) and its provincial offices: class I devices are filed, and class II and III devices are registered.⁠[1] Basic medical insurance covers most people; the National Healthcare Security Administration (NHSA) runs it and sets the National Reimbursement Drug List.⁠[2] ClinicalTrials.gov lists 20 studies on Bariatric Surgery Devices that are recruiting, active or about to start in China.⁠[3] Obesity (adults): 9.3% of adults in 2024, the latest WHO figure for China.⁠[4]

[1] National Medical Products Administration. Checked 14 Nov 2026.

[2] National Healthcare Security Administration. Checked 14 Nov 2026.

[3] ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in China. Retrieved 12 Nov 2026.

[4] WHO Global Health Observatory, Obesity (adults) (% of adults). Retrieved 15 Nov 2026.

Policy changes and Reimbursement scenario

Medical device rules, such as the US FDA 510(k) and PMA pathways and the EU Medical Device Regulation, govern how bariatric Surgery Devices products are approved and monitored. Reimbursement codes and hospital purchasing policies decide how widely they are used in China.

Beyond the market numbers

Research, trials and patients

What doctors and scientists are doing in Bariatric Surgery Devices right now, from free public sources.

Clinical trials

20 active trials in China

Recruiting, about to start, or running now.

Top trial sponsors (worldwide)

  1. Duomed 2 active trials on ClinicalTrials.gov (opens in a new tab)

Source: ClinicalTrials.gov, Industry lead sponsors of active studies found with this market's trial search, worldwide. Retrieved 13 Nov 2026.

See every trial on ClinicalTrials.gov (opens in a new tab)

Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, WHO Global Health Observatory, World Bank. Fetched 15 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.

Public data, with sources

Bariatric Surgery Devices in context

China compared

  • Obesity (adults): 9.3% of adults (2024). World: 16.2% of adults (2024). 10th highest of the 15 countries we cover in APAC.[1]
  • Health spending per person: 763 US$ per person (2023). World: 1,317 US$ per person (2023). 5th highest of the 15 countries we cover in APAC.[2]
  • Doctors: 3.11 per 1,000 people (2022). World: 1.86 per 1,000 people (2022). 3rd highest of the 15 countries we cover in APAC.[3]

[1] WHO Global Health Observatory, Obesity (adults) (% of adults). Retrieved 18 Nov 2026.

[2] World Bank Open Data, Health spending per person (US$ per person). Retrieved 17 Nov 2026.

[3] World Bank Open Data, Doctors (per 1,000 people). Retrieved 18 Nov 2026.

Free data on this topic

Quick answers

Frequently asked questions

How big is the Bariatric Surgery Devices market in China?
Placeholder estimate: about $221.6 Mn in 2025, rising to about $425.0 Mn by 2034. These are early estimates, not researched figures; the researched values come with the full report.
How fast is the Bariatric Surgery Devices market in China growing?
Placeholder estimate: about 7.5% a year (CAGR, 2025–2034). The researched growth rate comes with the full report.
What segments does the Bariatric Surgery Devices market report cover?
The report splits the market by device (Stapling Devices, Gastric Bands, Intragastric Balloons, Endoscopic Suturing Systems and more), procedure (Sleeve Gastrectomy, Gastric Bypass, Endoscopic Sleeve Gastroplasty) and end user (Hospitals, Ambulatory Surgical Centers, Diagnostic Centers, Home Care Settings).
Who are the key players in the Bariatric Surgery Devices market?
Key players include Johnson & Johnson, Medtronic, Apollo Endosurgery, Olympus Corporation, Intuitive Surgical and Allurion Technologies.
What is driving the Bariatric Surgery Devices market?
Rising rates of obesity and type 2 diabetes, strong clinical results for new weight-loss medicines and growing acceptance of obesity as a chronic disease are driving the bariatric Surgery Devices market.
Who regulates Bariatric Surgery Devices in China?
Medical devices are regulated by the National Medical Products Administration (NMPA) and its provincial offices: class I devices are filed, and class II and III devices are registered. Source: National Medical Products Administration. Checked 14 Nov 2026.
How is healthcare paid for in China?
Basic medical insurance covers most people; the National Healthcare Security Administration (NHSA) runs it and sets the National Reimbursement Drug List. Source: National Healthcare Security Administration. Checked 14 Nov 2026.
How many clinical trials on Bariatric Surgery Devices are running in China?
20 studies are recruiting, active or about to start in China, according to ClinicalTrials.gov. Source: ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in China. Retrieved 12 Nov 2026.
What does WHO report for China?
Obesity (adults): 9.3% of adults in 2024, the latest WHO figure. Source: WHO Global Health Observatory, Obesity (adults) (% of adults). Retrieved 15 Nov 2026.
How many people in China are 65 or older?
14.9% of people were 65 or older in 2025. Source: World Bank Open Data, Population ages 65 and above (% of total population), from UN population estimates. Retrieved 18 Nov 2026.
Back to Catalogue

Related Medical Devices reports in China

See all

Related on obesity and diabetes

See the topic